-

Komodo Health Appoints Mark Jewett to Chief Marketing Officer

Veteran marketing executive from Microsoft, Tableau, and Informatica to lead marketing and scale Komodo's AI-first strategy

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced the appointment of Mark Jewett as Chief Marketing Officer (CMO). Jewett will lead the company’s marketing, shaping brand, communications, and go-to-market strategy as it scales Marmot™ — its new AI platform designed to help Life Sciences and healthcare organizations innovate faster and serve patients better.

The appointment comes following a period of significant momentum for Komodo Health, including the recent launch of Marmot and recognition on the 2025 Forbes Cloud 100 and TIME's World's Top HealthTech Companies. As demand for AI-powered healthcare intelligence accelerates across the Life Sciences industry, Komodo is scaling to meet growing customer demand, requiring stronger marketing leadership to expand market awareness and drive platform deployment.

Jewett brings more than 25 years of experience leading marketing teams at major technology companies including Microsoft, Tableau, and Informatica. Throughout his career, he has focused on marketing data and AI solutions — from SQL Server and Azure at Microsoft to data analytics at Tableau and AI-powered data management at Informatica. He has a proven track record of leveraging technology and storytelling to drive growth at scale.

“Mark brings proven marketing leadership to meet the strong demand we’ve received for Marmot, our AI-powered healthcare intelligence platform designed to accelerate healthcare innovation and improve patient outcomes," said Web Sun, President and Co-Founder of Komodo Health. "His expertise in scaling marketing organizations and translating complex technology into compelling narratives positions him to amplify Komodo's market leadership as we advance our AI-first vision."

As CMO, Jewett will oversee all marketing functions, including brand strategy, product marketing, communications, demand generation, and go-to-market execution. He will be responsible for strengthening Komodo's market leadership and driving awareness of how Marmot is transforming the speed and rigor of critical healthcare decision-making.

"I'm excited to join Komodo at such a transformative moment," Jewett said. "Komodo is uniquely positioned to help apply AI to reduce the burden of disease. I've seen firsthand how the right combination of technology and storytelling can accelerate market adoption."

About Komodo Health

Komodo Health is on a mission to reduce the global burden of disease by building foundational AI for how Life Sciences and healthcare organizations discover, develop, and deliver life-saving therapies. The company's healthcare-native AI platform Marmot, powered by its Healthcare Map®, eliminates slow, fragmented analyses to accelerate critical healthcare decisions across the product life cycle — from trial design to launch strategy to post-market evidence generation. For more information, visit www.komodohealth.com.

Contacts

Media Contacts
Rowena Kelley
858.405.1971
media@komodohealth.com

Real Chemistry for Komodo Health
KomodoHealthTeam@realchemistry.com

Komodo Health


Release Versions

Contacts

Media Contacts
Rowena Kelley
858.405.1971
media@komodohealth.com

Real Chemistry for Komodo Health
KomodoHealthTeam@realchemistry.com

Social Media Profiles
More News From Komodo Health

Komodo Health Analysis Uncovers Dual Reality in Metastatic Breast Cancer Care: Rapid Targeted Cancer Therapy Adoption Amid Glaring Age-Related Disparities

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--On the 40th anniversary of Breast Cancer Awareness Month, a new analysis from Komodo Health, the leader in AI-powered healthcare intelligence, conducted in collaboration with the Tigerlily Foundation, a national breast cancer patient advocacy organization, delivers critical insights into antibody-drug conjugate (ADC) treatment patterns in metastatic breast cancer. The study confirms growing clinical acceptance of this innovative therapy but also reveal...

Komodo Health Recognized by Forbes, TIME, and The Healthcare Technology Report for Healthcare Analytics AI Innovation

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced that it has earned recognition on three prestigious industry lists: the 2025 Forbes Cloud 100, TIME’s inaugural World’s Top HealthTech Companies, and The Healthcare Technology Report’s Top 25 Healthcare Software Companies. These honors validate Komodo’s differentiated approach to healthcare analytics AI — purpose-built from the ground up rather than retrofitted from consum...

Breakthrough Alzheimer’s Therapies Drive Early Detection Rates While Exposing Deep Treatment Disparities

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--New research from Komodo Health and Medscape Education reveals both progress and persistent challenges in Alzheimer's disease care: Breakthrough therapies and targeted medical education are driving significant increases in early detection — with cognitive screening rising 10%, biomarker testing up 23%, and amyloid pathology testing surging more than 13-fold. However, patients at the highest risk are receiving treatments at the lowest rates. The analysi...
Back to Newsroom